In a study by Wu et al. (2023a), bone marrow transplantation was performed between MLKL−/− mice and wild-type mice, revealing that MLKL in the bone marrow could prevent alcohol-induced liver steatosis, inflammation, and other damage in ALD by affecting liver immune cell homeostasis and macrophage phagocytic capacity. This evidence concerns the gene MLKL and fatty liver disease.